Page last updated: 2024-09-02

tadalafil and tubastatin a

tadalafil has been researched along with tubastatin a in 1 studies

Compound Research Comparison

Studies
(tadalafil)
Trials
(tadalafil)
Recent Studies (post-2010)
(tadalafil)
Studies
(tubastatin a)
Trials
(tubastatin a)
Recent Studies (post-2010) (tubastatin a)
1,7423921,0891810174

Protein Interaction Comparison

ProteinTaxonomytadalafil (IC50)tubastatin a (IC50)
Histone deacetylase 8Schistosoma mansoni1.4791
Polyamine deacetylase HDAC10Danio rerio (zebrafish)0.22
Histone deacetylase 1Mus musculus (house mouse)8.1
Histone deacetylase 3Homo sapiens (human)3.0989
Histone deacetylase 4Homo sapiens (human)2.9738
Histone deacetylase 1Homo sapiens (human)2.8712
Histone deacetylase 7Homo sapiens (human)2.2908
Histone deacetylase 2Homo sapiens (human)4.5049
Polyamine deacetylase HDAC10Homo sapiens (human)3.3084
Histone deacetylase 11 Homo sapiens (human)9.9
Histone deacetylase 8Homo sapiens (human)1.1436
Histone deacetylase 6Homo sapiens (human)0.2209
Histone deacetylase 9Homo sapiens (human)3.7533
Histone deacetylase 5Homo sapiens (human)2.8138
Nuclear receptor corepressor 2Homo sapiens (human)3.5126
Histone deacetylase 6Mus musculus (house mouse)0.0044

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cuadrado-Tejedor, M; de Miguel, I; Espelosin, M; Estella-Hermoso de Mendoza, A; García-Barroso, C; Garcia-Osta, A; Haizhong, T; Musheng, X; Oyarzabal, J; Pérez-González, M; Rabal, O; Sáez, E; Sánchez-Arias, JA; Ugarte, A; Ursua, S; Wei, W1

Other Studies

1 other study(ies) available for tadalafil and tubastatin a

ArticleYear
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.
    European journal of medicinal chemistry, 2018, Apr-25, Volume: 150

    Topics: Alzheimer Disease; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Design; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Molecular Structure; Neuroglia; Phosphodiesterase 5 Inhibitors; Structure-Activity Relationship

2018